Transition Therapeutics, Inc. (TTHI) Reports Q2 Loss of $0.15, Had No Revenue
Tweet Send to a FriendGet Alerts TTHI Hot Sheet
Trade TTHI Now!
Transition Therapeutics, Inc. (NASDAQ: TTHI) reported Q2 EPS of ($0.15), versus $0.22 reported last year. Revenue for the quarter came in at $0 , versus $9.4 million reported last year.
For earnings history and earnings-related data on Transition Therapeutics, Inc. (TTHI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Transition Therapeutics, Inc. (TTHI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- GameStop Corp. (GME) Tops Q1 EPS by 6c; Boosts Lower-End of FY13 EPS Outlook
- Aeropostale, Inc. (ARO) Tops Q1 EPS by 1c; Guide for Wide Q2 Loss
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
